Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
SGRY 
Surgery Partners Inc (SGRY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: SGRY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
12 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $31.36
1 Year Target Price $31.36
| 8 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -42.14% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.81B USD | Price to earnings Ratio - | 1Y Target Price 31.36 |
Price to earnings Ratio - | 1Y Target Price 31.36 | ||
Volume (30-day avg) 12 | Beta 1.94 | 52 Weeks Range 18.87 - 33.97 | Updated Date 06/30/2025 |
52 Weeks Range 18.87 - 33.97 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.53 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.09% | Operating Margin (TTM) 11.55% |
Management Effectiveness
Return on Assets (TTM) 3.97% | Return on Equity (TTM) -0.35% |
Valuation
Trailing PE - | Forward PE 35.46 | Enterprise Value 6445832045 | Price to Sales(TTM) 0.89 |
Enterprise Value 6445832045 | Price to Sales(TTM) 0.89 | ||
Enterprise Value to Revenue 2.03 | Enterprise Value to EBITDA 13.16 | Shares Outstanding 128160000 | Shares Floating 25441921 |
Shares Outstanding 128160000 | Shares Floating 25441921 | ||
Percent Insiders 1.51 | Percent Institutions 110.89 |
Analyst Ratings
Rating 4 | Target Price 31.36 | Buy 1 | Strong Buy 8 |
Buy 1 | Strong Buy 8 | ||
Hold 3 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Surgery Partners Inc
Company Overview
History and Background
Surgery Partners Inc. was founded in 2004. It has grown through acquisitions and organic growth to become a leading operator of surgical facilities and related services in the United States.
Core Business Areas
- Surgical Facility Operations: Owns and operates a network of ambulatory surgery centers (ASCs) and surgical hospitals.
- Ancillary Services: Provides physician services, optical services, and other ancillary services.
Leadership and Structure
Wayne DeVeydt is the Chief Executive Officer. The company has a typical corporate structure with a board of directors and various executive leadership positions overseeing different business functions.
Top Products and Market Share
Key Offerings
- Ambulatory Surgery Centers (ASCs): Operates over 180 ASCs. These centers provide outpatient surgical procedures. Market share data is variable, but Surgery Partners holds a significant portion of the fragmented ASC market. Competitors include AmSurg (now part of Envision Healthcare), United Surgical Partners International (USPI), and HCA Healthcare (HCA).
- Surgical Hospitals: Operates surgical hospitals. Competitors include HCA Healthcare (HCA), Tenet Healthcare (THC), and Community Health Systems (CYH).
Market Dynamics
Industry Overview
The healthcare services industry, particularly the market for ambulatory surgery centers, is experiencing growth driven by an aging population, advancements in surgical techniques that allow for more outpatient procedures, and a focus on cost containment.
Positioning
Surgery Partners is positioned as a leading independent operator of surgical facilities, offering a lower-cost alternative to traditional hospital settings.
Total Addressable Market (TAM)
The US ambulatory surgery center market is estimated to be worth over $40 billion annually. Surgery Partners is positioned to capture a significant portion of this TAM through acquisitions and organic growth.
Upturn SWOT Analysis
Strengths
- Extensive network of surgical facilities
- Focus on high-growth surgical specialties
- Strong relationships with physicians
- Experienced management team
- Diversified revenue streams
Weaknesses
- High debt levels
- Exposure to reimbursement rate changes
- Dependence on physician referrals
- Integration risks from acquisitions
- Highly competitive market
Opportunities
- Further acquisitions of surgical facilities
- Expansion into new geographic markets
- Growth in demand for outpatient surgical procedures
- Development of new service lines
- Partnerships with health systems and payers
Threats
- Changes in healthcare regulations and reimbursement policies
- Increased competition from other surgical facility operators
- Rising operating costs
- Economic downturn
- Physician shortages
Competitors and Market Share
Key Competitors
- HCA
- THC
- USPI (United Surgical Partners International)
Competitive Landscape
Surgery Partners competes with larger hospital systems and other ASC operators. Its advantages include a focus on outpatient surgery and a cost-effective operating model. Disadvantages include its smaller size and higher debt levels compared to some competitors.
Major Acquisitions
Symetra Health
- Year: 2021
- Acquisition Price (USD millions): 350
- Strategic Rationale: Expanded market reach in the Phoenix, Arizona market and added complementary service offerings.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by both organic expansion and acquisitions of surgical facilities.
Future Projections: Analysts project continued revenue growth driven by increased demand for outpatient surgical procedures and further acquisitions.
Recent Initiatives: Recent initiatives include expanding the network through strategic acquisitions, focusing on high-growth surgical specialties, and improving operational efficiency.
Summary
Surgery Partners is a leading operator of surgical facilities with a strong network and focus on high-growth specialties. Its growth has been fueled by acquisitions, leading to high debt levels. The company faces competition and regulatory risks but is well-positioned to benefit from the increasing demand for outpatient surgery. Surgery Partners needs to manage its debt and integrate acquisitions effectively to achieve sustainable profitability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Surgery Partners Inc
Exchange NASDAQ | Headquaters Brentwood, TN, United States | ||
IPO Launch date 2015-10-01 | CEO & Director Mr. J. Eric Evans | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15000 | Website https://www.surgerypartners.com |
Full time employees 15000 | Website https://www.surgerypartners.com | ||
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.